Panelists discuss how emerging nonsurgical options such as hedgehog pathway inhibitors, immune checkpoint inhibitors, and photodynamic therapy are expanding treatment possibilities for patients with advanced basal cell carcinoma (BCC), particularly for those unsuitable for or unresponsive to traditional surgical interventions.
Panelists discuss how factors such as tumor size, location, patient age, and overall health guide the decision between surgical excision and nonsurgical treatments such as topical therapies or radiation for managing basal cell carcinoma (BCC) effectively.
Panelists discuss how a collaborative approach involving dermatologists, oncologists, and surgeons can optimize treatment outcomes and quality of life for patients with basal cell carcinoma through personalized, comprehensive care plans.
Panelists discuss how advanced basal cell carcinoma (BCC) management requires a nuanced approach, emphasizing the importance of early detection, multidisciplinary collaboration, personalized treatment strategies, and ongoing patient monitoring to optimize outcomes and quality of life.
Panelists discuss how setting long-term treatment goals for basal cell carcinoma (BCC) patients involves balancing factors such as disease control, quality of life, and potential adverse reactions to create personalized management plans that address both immediate concerns and future outcomes.
Panelists discuss how a complex case of advanced basal cell carcinoma (BCC) demonstrates the necessity for collaborative care across multiple specialties, highlighting the importance of tailored treatment strategies and coordinated management to achieve the best possible patient outcomes.
Panelists discuss how a multidisciplinary approach involving dermatologists, surgeons, radiation oncologists, and medical oncologists is crucial for optimal decision-making and management of complex basal cell carcinoma (BCC) cases, ensuring comprehensive care and improved patient outcomes.
Panelists discuss how advanced basal cell carcinoma (BCC) presents unique treatment challenges and examine recent developments that show promise for improving outcomes in patients with this aggressive form of skin cancer.
